|Articles|November 15, 2019
The Ins and Outs of Incorporating Patient Centricity in Drug Development
Author(s)Parexel
Related Content
Trending on PharmExec
1
Novartis to Layoff 322 NJ Employees: Report
2
Launch is Just the Beginning: Rare Disease Care Requires Durability
3
“AI as Reinvention”: Transforming the Business of Medicine
4
Pharma M&A Roundup: Chemomab Therapeutics Enters Merger Agreement with Scipher Medicine, Teva and Polpharma Biologics Enter Global Licensing Agreement
5